| |
| |
|
| Insider
Information: |
Gagnon Robert E. |
| Relationship: |
Director |
| City: |
Weston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
359,945 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,893,416 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
359,945 |
|
|
| Total
Value |
$3,893,416 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
18
|
|
Stock
price went up :
|
0
|
12
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 234.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Vice President, Finance |
2012-02-29 |
3,999 |
|
0 |
Premium* |
|
|
Clean Harbors Inc |
CLH |
EVP CFO and Treasurer |
2012-09-11 |
7,386 |
2012-09-11 |
0 |
Premium* |
|
|
Harvard Bioscience Inc |
HBIO |
Chief Financial Officer |
2018-08-29 |
321,169 |
2014-06-16 |
0 |
Premium* |
|
|
Verastem, Inc. |
VSTM |
Director |
2024-03-19 |
27,391 |
2018-08-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-11 |
4 |
AS |
$5.23 |
$738,999 |
D/D |
(141,300) |
386,829 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-08-07 |
4 |
AS |
$6.08 |
$608,091 |
D/D |
(100,015) |
349,286 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-11 |
4 |
OE |
$4.12 |
$490,840 |
D/D |
116,272 |
528,129 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-03-07 |
4 |
S |
$4.62 |
$448,542 |
D/D |
(97,087) |
357,938 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-08-07 |
4 |
OE |
$4.12 |
$420,200 |
D/D |
87,500 |
449,301 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-27 |
4 |
AS |
$5.54 |
$346,328 |
D/D |
(62,514) |
361,801 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
• – – |
2011-01-04 |
4 |
AS |
$66.55 |
$339,690 |
D/D |
(5,103) |
10,814 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-27 |
4 |
OE |
$4.12 |
$211,700 |
D/D |
50,000 |
424,315 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
• – – |
2011-01-04 |
4 |
OE |
$40.63 |
$198,415 |
D/D |
4,307 |
11,867 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-05-06 |
4 |
D |
$5.00 |
$130,405 |
D/D |
(26,081) |
331,857 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Chief Financial Officer |
• – – |
2021-08-12 |
4 |
D |
$2.87 |
$130,094 |
D/D |
(45,329) |
435,898 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2024-02-06 |
4 |
AS |
$13.70 |
$126,095 |
D/D |
(9,204) |
27,804 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Vice President, Finance |
• – – |
2012-02-24 |
4 |
AS |
$115.53 |
$121,769 |
D/D |
(1,054) |
5,885 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • – |
2024-01-12 |
4 |
AS |
$10.95 |
$100,784 |
D/D |
(9,204) |
37,008 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
• – – |
2011-03-02 |
4 |
AS |
$69.02 |
$98,164 |
D/D |
(1,402) |
9,486 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Vice President, Finance |
• – – |
2012-02-28 |
4 |
AS |
$115.03 |
$96,050 |
D/D |
(835) |
4,716 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
• – – |
2011-05-06 |
4 |
AS |
$96.13 |
$92,960 |
D/D |
(967) |
7,753 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
• – – |
2011-12-06 |
4 |
AS |
$112.31 |
$89,286 |
D/D |
(795) |
5,050 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
• – – |
2011-11-09 |
4 |
AS |
$112.04 |
$89,184 |
D/D |
(796) |
6,216 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Vice President, Finance |
• – – |
2012-02-29 |
4 |
AS |
$115.51 |
$82,821 |
D/D |
(717) |
3,999 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-09 |
4 |
AS |
$5.41 |
$76,822 |
D/D |
(14,200) |
411,857 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2018-07-10 |
4 |
AS |
$5.38 |
$73,706 |
D/D |
(13,700) |
411,857 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
• – – |
2011-10-03 |
4 |
AS |
$92.55 |
$72,004 |
D/D |
(778) |
7,635 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
• – – |
2011-02-24 |
4 |
AS |
$66.99 |
$70,606 |
D/D |
(1,054) |
11,223 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Vice President, Finance |
• – – |
2012-02-14 |
4 |
AS |
$118.61 |
$66,422 |
D/D |
(560) |
5,050 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
